Quantification of cystatin-C in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry.

Cystatin C (CysC)-based estimated glomerular filtration rate is an excellent marker for early diagnosis of Chronic Kidney Disease (CKD). Particle-enhanced nephelometric immunoassay (PENIA) and particle-enhanced turbidimetric immunoassay (PETIA) are commonly used methods for CysC quantification in clinical testing. However, both of them lack of specificity which mass spectrometry offers. In this paper, an isotope dilution liquid chromatography tandem mass spectrometry (ID-LC-MS/MS) method was established for quantification of CysC in human serum. After CysC denaturation, reduction and alkylation of cysteine residues, trypsin was added for proteolytic digestion of CysC. Specific peptide ALDFAVGEYNK was selected as surrogates for intact CysC protein, then quantified CysC by stable isotope-labelled internal standard peptide A[13C615N]LDFAVGEYNK based on calibration curve method. The calibration curves were y=0.1565x-1.6715 (R2=0.988) and y=1.8785x-2.2497 (R2=0.991) for y9 and y6, respectively. The linear range was 0.1-10mg/L and 0.5-15mg/L for y9 and y6, respectively. The limit of quantification (LOQ) was 0.052mg/L. At different concentrations of CysC, the recoveries were in the range of 80.5%-93.7%, the intraday precisions were in the range of 0.3%-2.2%, and the inter-day precisions were in the range of 0.2%-2.8%. The results show that ID-LC-MS/MS and PETIA methods have higher consistency (y=0.8021x+0.6611, p=0.14), and the mean difference of the two methods was -0.29mg/L, and 95% of the individual difference values were in the range of -0.91mg/L-0.33mg/L.

[1]  Validation of a new standardized cystatin C turbidimetric assay: evaluation of the three novel CKD-EPI equations in hypertensive patients. , 2013, Clinical biochemistry.

[2]  A. Attygalle,et al.  LC/MS characterization of undesired products formed during iodoacetamide derivatization of sulfhydryl groups of peptides. , 2007, Journal of mass spectrometry : JMS.

[3]  P. Rodríguez-González,et al.  Determination of Cystatin C in human serum by isotope dilution mass spectrometry using mass overlapping peptides. , 2015, Journal of proteomics.

[4]  Darryl B. Hardie,et al.  A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin. , 2010, Journal of proteome research.

[5]  Mark S Lowenthal,et al.  Quantitative bottom-up proteomics depends on digestion conditions. , 2014, Analytical chemistry.

[6]  J. Garin,et al.  Isotope dilution strategies for absolute quantitative proteomics. , 2009, Journal of proteomics.

[7]  N. Tyrefors,et al.  Two new types of assays to determine protein concentrations in biological fluids using mass spectrometry of intact proteins with cystatin C in spinal fluid as an example , 2014, Scandinavian journal of clinical and laboratory investigation.

[8]  A. Grubb,et al.  Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system. , 1979, Scandinavian journal of clinical and laboratory investigation.

[9]  F. Vandenesch,et al.  Isotope-labeled Protein Standards , 2007, Molecular & Cellular Proteomics.

[10]  Yun Chen,et al.  Quantification of human serum transferrin using liquid chromatography-tandem mass spectrometry based targeted proteomics. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  M. Shlipak,et al.  Update on cystatin C: incorporation into clinical practice. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  L L Needham,et al.  Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. , 1996, Clinical chemistry.

[13]  Xiaoqiang Ding,et al.  Clinical value of serum cystatin C by ELISA for estimation of glomerular filtration rate , 2004, Journal of clinical laboratory analysis (Print).

[14]  L. Hansson,et al.  Calibration of the Siemens cystatin C immunoassay has changed over time. , 2011, Clinical chemistry.

[15]  D. Nedelkov,et al.  Targeted quantitative mass spectrometric immunoassay for human protein variants , 2011, Proteome Science.

[16]  Toshihiro Kobayashi,et al.  A metabolomics-based approach for predicting stages of chronic kidney disease. , 2014, Biochemical and biophysical research communications.

[17]  Alexey I Nesvizhskii,et al.  Comprehensive analysis of protein digestion using six trypsins reveals the origin of trypsin as a significant source of variability in proteomics. , 2013, Journal of proteome research.

[18]  R. Sederoff,et al.  Understanding the role of proteolytic digestion on discovery and targeted proteomic measurements using liquid chromatography tandem mass spectrometry and design of experiments. , 2013, Journal of proteome research.

[19]  P. Ueland,et al.  Targeted quantification of C-reactive protein and cystatin c and its variants by immuno-MALDI-MS. , 2014, Analytical chemistry.

[20]  T. Larson,et al.  Analytic and clinical validation of a standardized cystatin C particle enhanced turbidimetric assay (PETIA) to estimate glomerular filtration rate , 2012, Clinical chemistry and laboratory medicine.

[21]  Andrew N Hoofnagle,et al.  Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry. , 2010, Clinical chemistry.

[22]  J. Van Bocxlaer,et al.  The use of tryptic marker-peptides for the quantitative analysis of cystatin C. , 2005, Journal of separation science.

[23]  E. Rodriguez.  Heavy labeling of recombinant proteins. , 2007, Methods in molecular biology.

[24]  A. Van der Laarse,et al.  Evaluation of interspecimen trypsin digestion efficiency prior to multiple reaction monitoring-based absolute protein quantification with native protein calibrators. , 2013, Journal of proteome research.

[25]  George G Klee,et al.  Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry. , 2004, Journal of proteome research.

[26]  Christoph H Borchers,et al.  A Human Proteome Detection and Quantitation Project* , 2009, Molecular & Cellular Proteomics.

[27]  M. Mann,et al.  Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.

[28]  S. Carr,et al.  Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry , 2013, Nature Methods.

[29]  Werner Zolg,et al.  Quantification of C‐reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C‐labeled peptide standards , 2004, Proteomics.

[30]  E. Boja,et al.  Overalkylation of a protein digest with iodoacetamide. , 2001, Analytical chemistry.

[31]  Andrew N Hoofnagle,et al.  The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. , 2009, Journal of immunological methods.

[32]  E. Gorodkiewicz,et al.  Cystatin C: a kidney function biomarker. , 2015, Advances in clinical chemistry.

[33]  K. Andrassy,et al.  Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'. , 2013, Kidney international.

[34]  A. Kribben,et al.  Measurement of urinary cystatin C by particle-enhanced nephelometric immunoassay: precision, interferences, stability and reference range , 2004, Annals of clinical biochemistry.

[35]  E. Dratz,et al.  Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. , 2003, Analytical chemistry.

[36]  Adam M. Hawkridge,et al.  Coupling of a vented column with splitless nanoRPLC-ESI-MS for the improved separation and detection of brain natriuretic peptide-32 and its proteolytic peptides. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.